Knowledge, attitude, and perception of public about participation in COVID-19 clinical trials: A study from Egypt and Saudi Arabia

Background: Pharmaceutical firms are striving to find potential treatments to prevent and treat COVID-19. One of the gold standards to evaluate treatment is a clinical trial; however, the difficulty in patient recruitment could act as a determinant. It is evident from the registry data that very few...

Full description

Bibliographic Details
Main Authors: Khaled Elshammaa, Nouran Hamza, Emad Elkholy, Ahmad Mahrous, Mohamed Hassan Elnaem, Mahmoud E Elrggal
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:Saudi Pharmaceutical Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016422000081